The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.

A manufacturing facility having approval from more than 25 different regulatory authorities including USFDA, MHRA, ANYISA etc. The facility is equipped to manufacture multiple dosage forms and has state of the art manufacturing setup and Quality Control Lab.

Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.

Walk In Drive at Udaipur

Lincoln Pharmaceuticals Ltd., Ahmedabad based 40 years old, public limited having presence in 75+ countries, 1700+ registered products, own Manufacturing and R&D center and among india’s top 70 pharma company.

Glenmark Pharmaceutical Ltd, Baddi (H.P.) A manufacturing facility having approval from more than 25 different regulator authorities including USFDA, MHRA, ANVISA etc. The facility is equipped to manufacture multiple dosage forms and has state of the art manufacturing setup and Quality Control Lab.

Looking for professionals having experience in formulations of MDI/lnhalers, External preparation, sterile and Liquids.

Surgical removal of the tonsils and adenoids in children with snoring and mild breathing problems during sleep appears to improve their sleep, quality of life, and blood pressure a year after surgery, a clinical trial supported by the National Institutes of Health has found. The study, funded by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, is believed to be the first large, randomized trial to address the effects of adenotonsillectomy on children with mild sleep-disordered breathing (SDB).

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

To speed up their growth, leukemia cells typically activate the recycling of cellular structures – enabling them to dispose of defective components and better supply themselves with building materials. Researchers at Goethe University Frankfurt have now shown that leukemia cells with a very common mutation activate specific genes that are important for this recycling process. Their findings, published in the journal Cell Reports, open up new therapeutic options for the future.

Self-folding polymers containing gadolinium forming nanosized complexes could be the key to enhanced magnetic resonance imaging and next-generation drug delivery, as demonstrated by scientists at Tokyo Tech. Thanks to their small size, low toxicity, and good tumor accumulation and penetration, these complexes represent a leap forward in contrast agents for cancer diagnosis, as well as neutron capture radiotherapy.

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Fabhalta® (iptacopan) as the first oral monotherapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH). Fabhalta is a Factor B inhibitor that acts proximally in the alternative complement pathway of the immune system, providing comprehensive control of red blood cell (RBC) destruction within and outside the blood vessels (intra- and extravascular hemolysis [IVH and EVH]).

Completed applications are invited from eligible persons for temporary employment on contract basis for the vacant posts of District Project Manager, Data Assistant Pharmacist and Multidisciplinary Health Worker under NHM Scheme in AYSUS Division in Thanjavur District Siddha Medical Office on 15.12.2023 by 5.00 PM. The following posts are purely temporary.  No post will be made permanent. At the end of II months, 1 day post will be broken and re-appointment will be given.

Northern Institute of Pharmacy & Research, Alwar established in the year 2017-18 under the aegis the Groupnet Education Welfare Society is one of premier pharmacy colleges imparting quality pharmaceutical education and training institute in Rajasthan. NIPR, Alwar mission has been to train pharmacy graduates and generate the most challenging technologies to serve and support the health care community. The institute has state of the art-infrastructure and instrumental facilities and provide a severe atmosphere for academic excellence.

Applications are invited to fill up the Specialist Doctors, Paramedical staffs and Community Health Officer to the following Ayush hospitals temporarily, Purely on Contract basis. Applications available in hassan.nic.in and Submitted to District Ayush Office from Date : 29-11-2023 on all working days between 10:00 Am to 4:30 Pm. Last date for receiving duly filled applications is 28-12-2023 4:30 Pm. Incomplete applications & applications received after the last date will not be considered.

Shri Vinayak Education Society managing Siddhi Vinayak Group of Institutions was formed by a group of Educationists for the promotion of good Colleges, Institutions and Schools in various parts of Delhi and neighbor states. The Promoters of the Engineering college and other colleges are running one of the biggest Centrally Air Conditioned School and B.Ed. College at Delhi for the last 14 years having vast knowledge in providing best ever Educational atmosphere & facilities.

Regional Centre for Biotechnology (RCB) is an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

The National Institute of Mental Health and Neuro Sciences (NIMHANS) is a multidisciplinary institute for patient care and academic pursuit in the field of mental health and neurosciences.  NIMHANS is synonymous with providing high standards of clinical care, quality training and cutting-edge research in the frontier areas. Combined priorities for comprehensive patient care, manpower development and research, stem from the commitment to an integrated and multidisciplinary approach which addresses societal needs.

The Institute for Stem Cell Science & Regenerative Medicine, Bangalore is an autonomous institute under the Department of Biotechnology, Ministry of Science & Technology, Government of India. DBT-inStem’s mandate is to establish collaborative research programs in the field of stem cell biology, regeneration, and repair in development and disease, with translational emphasis.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India.  The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Recruiting for our Injectable and OSD manufacturing plant located at Ahmedabad